Cellectis (NASDAQ:CLLS) Upgraded to “Buy” at StockNews.com
Cellectis (NASDAQ:CLLS – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” rating in a note issued to investors on Friday. Cellectis Price Performance CLLS stock opened at $1.53 on Friday. The stock has a market cap of $85.04 million, a price-to-earnings ratio of -1.18 and a […]
Cellectis (NASDAQ:CLLS – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” rating in a note issued to investors on Friday. Cellectis Price Performance CLLS stock opened at $1.53 on Friday. The stock has a market cap of $85.04 million, a price-to-earnings ratio of -1.18 and a […]
